Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KX2-391 + Paclitaxel in Advanced Solid Tumors
NCT01764087Phase 2Unknown
- Sponsor
- Hanmi Pharmaceutical
- Start
- Dec 2012
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirbanibulin in gastric cancer (GC), breast cancer, solid tumor, sponsored by Hanmi Pharmaceutical. Status: unknown.
02
Drugs
tirbanibulin
03
Conditions
gastric cancer (GC)breast cancersolid tumor
Beyond the preview
Go deeper on NCT01764087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01764087.